Personalized proteomics in proliferative vitreoretinopathy implicate hematopoietic cell recruitment and mTOR as a therapeutic target

Authors:

N. Roybal; G. Velez; M.A. Toral; S.H. Tsang; A.G. Bassuk; V.B. Mahajan

Citation:

C Roybal N, Velez G, Toral MA, Tsang SH, Bassuk AG, Mahajan VB. "Personalized proteomics in proliferative vitreoretinopathy implicate hematopoietic cell recruitment and mTOR as a therapeutic target." American journal of ophthalmology. 2017.

Year of Publication:

2017